 |
|
|
| |
Summary of pharmacokinetic drug-drug interactions for simeprevir (TMC435), a hepatitis C virus Ns3/4A protease inhibitor
|
| |
| |
Reported by Jules Levin
14th European AIDS Conference (EACS)
16-19 October 2013 · Brussels, Belgium
Sivi Ouwerkerk-Mahadevan,1 Alexandru simion,2 Monika Peeters,2 Maria Beumont-Mauviel2
1Janssen Research and Development, Beerse, Belgium; 2Janssen Infectious Diseases, Beerse, Belgium
Address correspondence to:
Sivi Ouwerkerk-Mahadevan,
Janssen Research & Development,
Turnhoutseweg 30, Beerse,
2340 Belgium.
e mail: SOUWERKE@its.jnj.com
Tel: 0032 (0)14605730
|
| |
|
|
|
|
|
